Faron Pharmaceuticals Reports Major Holdings Shift
Company Announcements

Faron Pharmaceuticals Reports Major Holdings Shift

Faron Pharmaceuticals Oy (GB:FARN) has released an update.

Faron Pharmaceuticals Oy has reported a change in major holdings following a recent share offering, with a notification indicating a decrease in the total percentage of voting rights held by Markku Jalkanen and Sirpa Jalkanen from 4.69% to 3.26%. This notification follows the event that crossed the threshold on June 20, 2024, and was reported on the same day, showcasing the dynamic nature of the company’s shareholder structure.

For further insights into GB:FARN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskFaron Pharmaceuticals Issues New Share Options
TipRanks UK Auto-Generated NewsdeskFDA Fast-Tracks Faron’s Bexmarilimab for r/r MDS
TipRanks UK Auto-Generated NewsdeskFaron Pharmaceuticals Rallies with Bexmarilimab Success
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App